CB

Coagulare Biomedica

Europe, Buckinghamshire, United Kingdom, Beaconsfield

Description

Coagulare Biomedica

Investor Profile

Coagulare Biomedica has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Coagulare Biomedica frequently co-invest with?

Lancaster Capital
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
Kelvin Capital
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
Scottish Enterprise
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
Ingenza
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1

What are some of recent deals done by Coagulare Biomedica?

ProFactor Pharma

Newhouse, North Lanarkshire, United Kingdom

ProFactor Pharma provides commercialise and supply recombinant blood factors for the treatment of haemophilia.

BiotechnologyHealth CareMedical
Series UnknownMar 21, 2015
Amount Raised: $137,572